""

Gastric cancer

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Metastatic Disease: First-Line-Therapy

Title: Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction (FLOT5)
Phase: III
Contact: Mirjam Campbell / (Study Nurse)
Email-Address: Mirjam.Campbell@med.uni-heidelberg.de
Clinical Investigator: PD Dr. Georg Martin Haag
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT02578368
EudraCT-Number: siehe EU klinisches Studienregister 2014-002665-30

Metastatic Disease: Follow-Up Care

Title: A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Participants with Advanced Gastric Cancer
Phase: II
Contact: Mirjam Campbell / (Study Nurse)
Email-Address: Mirjam.Campbell@med.uni-heidelberg.de
Clinical Investigator: PD Dr. Georg Martin Haag
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT02935634
EudraCT-Number: siehe EU klinisches Studienregister 2016-002807-24
Title: A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects with Previously Treated NTRK Fusion Cancers.
Phase: I/II
Contact: Barbara Stöhr / (Study Nurse)
Email-Address: barbara.stoehr@nct-heidelberg.de
Clinical Investigator: Prof. Dr. Richard Schlenk
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT03215511
EudraCT-Number: siehe EU klinisches Studienregister 2017-004246-20

Other study

There are currently no studies available